查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1564069

心肺自动输血系统的全球市场

Cardiopulmonary Autotransfusion Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年，全球心肺自动输血系统市场预计将达到7.596亿美元

心肺自动输血系统的全球市场预计2023年为6.538亿美元，预计2030年将达到7.596亿美元，2023-2030年分析期间复合年增长率为2.2%。体外循环输血设备是本报告分析的细分市场之一，预计复合年增长率为 2.4%，到分析期结束时将达到 5.238 亿美元。在分析期间，非体外循环输血装置领域的复合年增长率预计为 1.7%。

美国市场预估为1.759亿美元，中国预期复合年增长率为1.7%

2023年美国心肺自动输血系统市场预估为1.759亿美元。中国作为世界第二大经济体，预计2030年市场规模将达到1.18亿美元，2023-2030年分析期间复合年增长率为1.7%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 2.2% 和 1.4%。在欧洲，德国的复合年增长率预计为 1.6%。

全球心肺自动输血系统市场－主要趋势与驱动因素总结

心肺自动输血系统为手术中的血液管理带来了什么样的革命？

心肺自动输血系统允许患者在手术过程中收集和重复使用自己的血液，在现代外科手术中发挥重要作用。这种系统在经常流失大量血液的手术中尤其重要，例如心血管手术手术或创伤手术。传统上，输血依赖捐血，但这种方法有感染疾病、免疫反应和血液短缺等风险。自体输血系统透过在手术期间收集、过滤和回输患者自己的血液来缓解这些问题。这不仅减少了对捐血的需求，也降低了与输血反应相关的风险。此外，这些系统可确保患者获得更新鲜、更相容的血液，从而缩短恢復时间并降低术后併发症的可能性。在心肺手术中，有效管理失血至关重要，自动输血系统对于维持患者稳定性和减少医疗保健系统中对捐血的整体需求至关重要。

科技如何改善心肺自动输血系统？

技术进步显着提高了心肺自动输血系统的效率和可靠性，使其能够更有效地控制术中出血。最新的自动化输血机采用先进的过滤和分离技术，以确保更高品质的回输。这些系统可以有效地将红血球与脂肪、骨头碎片和血块等污染物分离，只允许过滤后的洁净血液回流到病人体内。此外，新系统更加紧凑且用户友好，可以更快地设定并更轻鬆地整合到手术工作流程中。这些设备的便携性意味着它们可以在从大型心血管手术到创伤中心的各种环境中使用，而无需笨重的固定设备。此外，自动化处理系统的引入减少了所需的体力劳动，最大限度地减少了人为错误的可能性，并提高了自动化输血过程的安全性和可靠性。许多现代系统还包括即时监控和资料收集功能，使手术团队能够在整个手术过程中追踪血液量和质量，以确保最佳的患者治疗效果。这些创新显着提高了自动化输血系统在复杂手术期间提供安全高效血液管理的能力。

什么趋势正在塑造心肺自动输血系统市场？

几个关键趋势正在影响心肺自动输血系统市场的成长和开拓，反映了医疗保健实践和手术技术的更广泛转变。一个主要趋势是越来越关注患者安全并减少与同种异体输血相关的併发症。随着人们对与捐赠者输血相关的风险（例如感染疾病和免疫反应）的认识不断提高，越来越多的医疗保健提供者正在采用自动输血系统作为更安全的替代方案。此外，捐赠者血液供不应求以及与血液储存和输血相关的高成本增加了手术环境中对血液储存技术的需求。向微创手术的转变也正在影响市场。儘管这些手术侵入性较小，但由于出血风险，它们仍然需要有效的血液管理系统。这一趋势导致了更小、更便携的自体输血设备的开发，这些设备可以适应各种手术环境。此外，随着世界各地的医疗保健系统越来越注重降低医疗成本，自动输血系统作为一种具有成本效益的解决方案越来越受到关注。透过减少对昂贵捐血的需求并最大限度地减少术后併发症，这些系统可以帮助医院更有效地管理资源，同时改善患者的治疗效果。

推动心肺自动输血系统市场成长的关键因素是什么？

技术进步、病人安全意识的提高以及对高效血液管理解决方案的需求不断增加共同推动了心肺自动输血系统市场的成长。主要驱动因素之一是人们对同种异体输血的安全性日益关注，这种输血可能带来感染疾病、过敏反应和免疫抑制等风险。随着医疗保健提供者优先考虑患者安全，自动输血系统的采用不断增加，提供了安全的替代方案，可以最大限度地降低这些风险。另一个重要的驱动因素是捐血成本上升和稀缺，特别是在血液供应基础设施有限的地区。自体输血系统透过重复使用患者自己的血液、减少对捐血的依赖并降低整体医疗保健成本，提供了一种经济高效的解决方案。技术进步也在市场扩张中发挥重要作用。现代自体输血系统是复杂外科手术的首选，尤其是心臟、整形外科和创伤病例，因为它们更有效、更容易使用，并且可以实现更高品质的回输。微创手术的日益普及进一步增加了对紧凑型便携式可携式输血系统的需求，这些系统可以无缝整合到各种手术环境中。此外，医疗保健提供者越来越关注血液保护策略，以改善资源管理，而自动输血系统被认为是这方面的有效工具。此外，监管机构和医疗机构正在推广包括自动输血在内的血液管理通讯协定，进一步推动这些系统在医院和外科中心的采用。这些综合因素预计将在未来几年继续推动心肺自动输血系统市场的成长。

受访企业范例（12家知名企业）

  • Atrium Medical Corporation
  • Fresenius SE & Co. KGaA
  • Global Blood Resources, LLC
  • Haemonetics Corporation
  • LivaNova PLC
  • Medtronic PLC
  • Redax SpA
  • Stryker Corporation
  • Terumo Medical Corporation-Terumo Interventional Systems

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP10901

Global Cardiopulmonary Autotransfusion Systems Market to Reach US$759.6 Million by 2030

The global market for Cardiopulmonary Autotransfusion Systems estimated at US$653.8 Million in the year 2023, is expected to reach US$759.6 Million by 2030, growing at a CAGR of 2.2% over the analysis period 2023-2030. On-Pump Transfusion Device, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$523.8 Million by the end of the analysis period. Growth in the Off-Pump Transfusion Device segment is estimated at 1.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$175.9 Million While China is Forecast to Grow at 1.7% CAGR

The Cardiopulmonary Autotransfusion Systems market in the U.S. is estimated at US$175.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$118.0 Million by the year 2030 trailing a CAGR of 1.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 1.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Global Cardiopulmonary Autotransfusion Systems Market - Key Trends and Drivers Summarized

How Are Cardiopulmonary Autotransfusion Systems Revolutionizing Blood Management in Surgery?

Cardiopulmonary autotransfusion systems play a crucial role in modern surgical procedures by allowing patients to recover and reuse their own blood during surgery. These systems are particularly essential in cardiac and trauma surgeries, where significant blood loss is common. Traditionally, blood transfusions have relied on donor blood, but this approach carries risks such as infections, immune reactions, and blood shortages. Autotransfusion systems mitigate these issues by collecting, filtering, and reinfusing the patient’s own blood during the surgical procedure. This not only reduces the need for donor blood but also decreases the risks associated with transfusion reactions. Additionally, these systems ensure that patients receive fresher and more compatible blood, improving recovery times and reducing the likelihood of postoperative complications. In the context of cardiopulmonary surgeries, where managing blood loss efficiently is paramount, autotransfusion systems have become indispensable in maintaining patient stability and reducing the overall demand for donor blood in the healthcare system.

How Has Technology Improved Cardiopulmonary Autotransfusion Systems?

Technological advancements have significantly enhanced the efficiency and reliability of cardiopulmonary autotransfusion systems, making them more effective in managing intraoperative blood loss. Modern autotransfusion devices are now equipped with advanced filtration and separation technologies that ensure higher-quality blood reinfusion. These systems can effectively separate red blood cells from contaminants like fat, bone fragments, and clots, ensuring that only clean, filtered blood is returned to the patient. Additionally, newer systems are more compact and user-friendly, allowing for faster setup and easier integration into surgical workflows. The portability of these devices means they can be used in a variety of settings, from major cardiac surgeries to trauma centers, without the need for large, stationary machines. Furthermore, the introduction of automated processing systems has reduced the manual intervention required, minimizing the chance of human error and improving the safety and reliability of the autotransfusion process. Many of the latest systems also feature real-time monitoring and data collection capabilities, which allow surgical teams to track blood volume and quality throughout the procedure, ensuring optimal patient outcomes. These technological innovations have greatly improved the ability of autotransfusion systems to provide safe, efficient blood management during complex surgeries.

What Trends Are Shaping the Cardiopulmonary Autotransfusion Systems Market?

Several key trends are influencing the growth and development of the cardiopulmonary autotransfusion systems market, reflecting broader shifts in healthcare practices and surgical technologies. One major trend is the increasing emphasis on patient safety and the reduction of complications related to allogeneic blood transfusions. As awareness of the risks associated with donor blood transfusions, such as infections and immune reactions, grows, more healthcare providers are adopting autotransfusion systems as a safer alternative. Additionally, there is a rising demand for blood conservation techniques in surgical settings, driven by shortages in donor blood supplies and the high costs associated with blood storage and transfusion. The shift towards minimally invasive surgeries is also impacting the market, as these procedures, although less invasive, still require efficient blood management systems due to the risk of bleeding. This trend has led to the development of smaller, more portable autotransfusion devices that are adaptable to a range of surgical environments. Moreover, as healthcare systems worldwide place increasing importance on reducing healthcare costs, autotransfusion systems are gaining traction as a cost-effective solution. By reducing the need for expensive donor blood and minimizing postoperative complications, these systems help hospitals manage resources more efficiently while improving patient outcomes.

What Are the Major Factors Driving Growth of the Cardiopulmonary Autotransfusion Systems Market?

The growth in the cardiopulmonary autotransfusion systems market is driven by a combination of technological advancements, increased awareness of patient safety, and the rising demand for efficient blood management solutions. One of the primary drivers is the growing concern over the safety of allogeneic blood transfusions, which can carry risks such as infections, allergic reactions, and immune suppression. As healthcare providers prioritize patient safety, the adoption of autotransfusion systems is increasing, offering a safer alternative that minimizes these risks. Another significant driver is the rising cost and shortage of donor blood, particularly in regions with limited blood supply infrastructure. Autotransfusion systems provide a cost-effective solution by recycling the patient’s own blood, reducing the dependency on donor blood and lowering overall healthcare costs. Advancements in technology have also played a major role in expanding the market. Modern autotransfusion systems are more efficient, user-friendly, and capable of delivering higher-quality blood reinfusion, making them a preferred choice in complex surgeries, especially in cardiac, orthopedic, and trauma cases. The growing popularity of minimally invasive surgeries has further increased the demand for compact, portable autotransfusion systems that can be seamlessly integrated into different surgical environments. Additionally, healthcare providers are increasingly focused on blood conservation strategies to improve resource management, and autotransfusion systems are seen as an effective tool in this regard. Moreover, regulatory bodies and healthcare organizations are promoting blood management protocols that include autotransfusion, further driving the adoption of these systems across hospitals and surgical centers. These combined factors are expected to continue fueling the growth of the cardiopulmonary autotransfusion systems market in the coming years.

Select Competitors (Total 12 Featured) -

  • Atrium Medical Corporation
  • Fresenius SE & Co. KGaA
  • Global Blood Resources, LLC
  • Haemonetics Corporation
  • LivaNova PLC
  • Medtronic PLC
  • Redax SpA
  • Stryker Corporation
  • Terumo Medical Corporation -Terumo Interventional Systems

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cardiopulmonary Autotransfusion Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Minimally Invasive Surgery Propel Growth of Cardiopulmonary Autotransfusion Systems
    • Aging Population and Increased Cardiovascular Procedures Spur Demand for Autotransfusion Technologies
    • Rising Concerns over Blood Safety and Infection Risks Strengthen the Business Case for Autotransfusion Systems
    • Increased Adoption of Enhanced Filtration Technologies Drives Penetration of Next-Generation Autotransfusion Systems
    • Focus on Blood Conservation in Surgical Procedures Propels Adoption of Autotransfusion Devices
    • Integration of Advanced Monitoring and AI in Autotransfusion Systems Drives Technological Innovation
    • Growing Popularity of Outpatient and Ambulatory Surgical Centers Expands Opportunities for Portable Autotransfusion Systems
    • Surge in Complex Cardiovascular Surgeries Generates Demand for High-Capacity Autotransfusion Devices
    • Here's How Remote Monitoring Capabilities in Autotransfusion Systems Are Transforming Post-Surgical Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiopulmonary Autotransfusion Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cardiopulmonary Autotransfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for On-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for On-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for On-Pump Transfusion Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Off-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Off-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Off-Pump Transfusion Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Cardiopulmonary Autotransfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: France 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: UK 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Rest of Europe Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Rest of Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Asia-Pacific 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of World Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of World 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030

IV. COMPETITION